Companies: 10,795·Total market cap: $144.5T
GlobeStar Therapeutics Corporation

GlobeStar Therapeutics Corporation

GSTCOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$124111
P/E Ratio
52W High$0.0001
52W Low$0.0001
Overview

GlobeStar Therapeutics Corporation (GSTC) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

GSTC · earnings · updated Jun 9, 2026

Latest Earnings

Q4 FY2024
EPS Actual
-$0.00
Revenue
Fiscal Period
Q4 FY2024
FY ends December
Report Date
Oct 11, 2024
After Market Close
GSTC reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.

EPS & Revenue vs. Estimates

Actual (Beat)
Actual (Miss)
Estimated

Earnings History

Q4 FY2024
Oct 11, 2024
EPS Actual
-$0.00
EPS Est.
EPS Surpr.
Revenue
Q2 FY2024
Jun 28, 2024
EPS Actual
-$0.00
EPS Est.
EPS Surpr.
Revenue
Q1 FY2024
Mar 11, 2024
EPS Actual
-$0.00
EPS Est.
EPS Surpr.
Revenue
Q1 FY2024
Jan 19, 2024
EPS Actual
-$0.00
EPS Est.
EPS Surpr.
Revenue
Q3 FY2023
Aug 17, 2023
EPS Actual
-$0.00
EPS Est.
EPS Surpr.
Revenue
Q2 FY2023
May 31, 2023
EPS Actual
-$0.00
EPS Est.
EPS Surpr.
Revenue
Q1 FY2023
Feb 13, 2023
EPS Actual
-$0.00
EPS Est.
EPS Surpr.
Revenue
Q1 FY2023
Jan 9, 2023
EPS Actual
-$0.00
EPS Est.
EPS Surpr.
Revenue
No analyst estimates available for GSTC.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.
Q4 FY2024+25.00%
Report Date
Oct 11, 2024
EPS Beat/Miss
Price Before
$0.00
Price After
$0.00
Q2 FY2024+0.00%
Report Date
Jun 28, 2024
EPS Beat/Miss
Price Before
$0.00
Price After
$0.00
Q1 FY2024+2.86%
Report Date
Mar 11, 2024
EPS Beat/Miss
Price Before
$0.00
Price After
$0.00
Q1 FY2024+20.00%
Report Date
Jan 19, 2024
EPS Beat/Miss
Price Before
$0.00
Price After
$0.00
Q3 FY2023-11.97%
Report Date
Aug 17, 2023
EPS Beat/Miss
Price Before
$0.00
Price After
$0.00
Q2 FY2023+5.26%
Report Date
May 31, 2023
EPS Beat/Miss
Price Before
$0.00
Price After
$0.00
Q1 FY2023+12.12%
Report Date
Feb 13, 2023
EPS Beat/Miss
Price Before
$0.01
Price After
$0.01
Q1 FY2023-15.00%
Report Date
Jan 9, 2023
EPS Beat/Miss
Price Before
$0.01
Price After
$0.01
Beat Rate0 / 8 quarters
Largest Move+25.00% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: GSTC ends December

GlobeStar Therapeutics Corporation (GSTC) most recently reported earnings on October 11, 2024 for Q4 FY2024, posting EPS of $-0.00 (in line with the analyst consensus of —). The next GSTC earnings date is expected around September 1, 2026.

Each quarter, investors track GSTC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GSTC revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GSTC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Frequently asked questions

GSTC earnings · 4 questions

GlobeStar Therapeutics Corporation's next earnings report is expected around September 1, 2026. GSTC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GSTC historically reports after market close (AMC).

GSTC earnings datewhen is GSTC earningsGSTC next earnings datewhen does GSTC report earningsGSTC earnings calendar

Source: FMP · GlobeStar Therapeutics Corporation SEC filings · US GAAP · GlobeStar Therapeutics Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026